{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T13:15:07Z","timestamp":1775654107116,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T00:00:00Z","timestamp":1760313600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Pingyang Science and Technology program","award":["Y2024A01"],"award-info":[{"award-number":["Y2024A01"]}]},{"name":"The Pingyang Science and Technology program","award":["Y2024A01"],"award-info":[{"award-number":["Y2024A01"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Abdom Radiol"],"DOI":"10.1007\/s00261-025-05231-0","type":"journal-article","created":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T05:40:49Z","timestamp":1760334049000},"page":"2555-2568","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Development and validation of a nomogram combining PI-RADS v2.1 and clinical indicators for the diagnosis of prostate cancer in patients with PSA\u2009\u2264\u200920 ng\/mL"],"prefix":"10.1007","volume":"51","author":[{"given":"Zhilian","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bufeng","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luyao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhaohai","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuchuan","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,13]]},"reference":[{"key":"5231_CR1","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J Clin. (2018) 68:394\u2013424. doi: https:\/\/doi.org\/10.3322\/caac.21492","journal-title":"CA: Cancer J Clin"},{"issue":"3","key":"5231_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1053\/j.semnuclmed.2021.11.013","volume":"52","author":"Asha Daryanani","year":"2022","unstructured":"Daryanani, Asha, and Baris Turkbey. \u201cRecent Advancements in CT and MR Imaging of Prostate Cancer.\u201d Seminars in nuclear medicine vol. 52,3 (2022): 365\u2013373. doi:https:\/\/doi.org\/10.1053\/j.semnuclmed.2021.11.013.","journal-title":"Seminars in nuclear medicine"},{"issue":"Suppl 23","key":"5231_CR3","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1002\/cncr.29052","volume":"120","author":"MJ Schymura","year":"2014","unstructured":"Schymura MJ, Sun L and Percy-Laurry A. Prostate cancer collaborative stage data items--their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. Cancer 2014; 120 Suppl 23: 3758\u20133770.","journal-title":"Cancer"},{"key":"5231_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/modpathol.3800054","volume":"17","author":"PA Humphrey","year":"2004","unstructured":"Humphrey PA. Gleason grading and prognostic factors in carcinoma of the prostate. Mod Pathol 2004; 17: 292\u2013306.","journal-title":"Mod Pathol"},{"issue":"4","key":"5231_CR5","first-page":"272","volume":"1","author":"YT Liang","year":"2010","unstructured":"Liang YT, Jin EH, Zhang Y, et al. Diffusion-weighted imaging in the detection and differentiation of prostate cancer. Chin J Magn Reson Imaing, 2010, 1(4): 272\u2013276.","journal-title":"Chin J Magn Reson Imaing"},{"key":"5231_CR6","doi-asserted-by":"publisher","unstructured":"Grobner T. Gadoliniuma-- specific trigger for the development of nephrogenic fibrosing dermopathy and nephrogenic systemic fibrosis? [J]. Nephrol Dial Transplant, 2006, 21(4): 1104\u20431108. DOI: https:\/\/doi.org\/10.1093\/ndt\/gfk062.","DOI":"10.1093\/ndt\/gfk062"},{"issue":"3","key":"5231_CR7","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1148\/radiol.13131669","volume":"270","author":"T Kanda","year":"2014","unstructured":"Kanda T, Ishii K, Kawaguchi H, et al. High signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images: relationship with increasing cumulative dose of a gadolinium -based contrast material[J]. Radiology, 2014,270(3):834\u2013841. DOI: https:\/\/doi.org\/10.1148\/radiol.13131669.","journal-title":"Radiology"},{"key":"5231_CR8","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1007\/s00330-017-5065-8","volume":"28","author":"Ilona A Dekkers","year":"2018","unstructured":"Dekkers, Ilona A et al. \u201cGadolinium retention after administration of contrast agents based on linear chelators and the recommendations of the European Medicines Agency.\u201d European radiology vol. 28,4 (2018): 1579\u20131584. doi:https:\/\/doi.org\/10.1007\/s00330-017-5065-8.","journal-title":"European radiology"},{"key":"5231_CR9","doi-asserted-by":"publisher","first-page":"3995789","DOI":"10.1155\/2021\/3995789","volume":"2021","author":"ZB Wang","year":"2021","unstructured":"Wang ZB, Wei CG, Zhang YY, Pan P, Dai GC, Tu J, Shen JK. The Role of PSA Density among PI-RADS v2.1 Categories to Avoid an Unnecessary Transition Zone Biopsy in Patients with PSA 4-20\u2009ng\/mL. Biomed Res Int. 2021;2021:3995789. doi: https:\/\/doi.org\/10.1155\/2021\/3995789. PMID: 34671673; PMCID: PMC8523253.","journal-title":"Biomed Res Int"},{"key":"5231_CR10","doi-asserted-by":"publisher","first-page":"e929913","DOI":"10.12659\/MSM.929913","volume":"27","author":"M Chen","year":"2021","unstructured":"Chen M, Ma T, Li J, Zhang HJ, Li Q, Wang JJ, Sang T, Cao CL, Cui XW. Diagnosis of Prostate Cancer in Patients with Prostate-Specific Antigen (PSA) in the Gray Area: Construction of 2 Predictive Models. Med Sci Monit. 2021;27:e929913. doi: https:\/\/doi.org\/10.12659\/MSM.929913. PMID: 33556045; PMCID: PMC7879585.","journal-title":"Med Sci Monit"},{"key":"5231_CR11","doi-asserted-by":"publisher","unstructured":"Deering, R E et al. \u201cMorphometric quantitation of stroma in human benign prostatic hyperplasia.\u201d Urology vol. 44,1 (1994): 64-70. https:\/\/doi.org\/10.1016\/s0090-4295(94)80011-1.","DOI":"10.1016\/s0090-4295(94)80011-1"},{"key":"5231_CR12","author":"JC Weinreb","year":"2016","unstructured":"Weinreb JC, Barentsz JO, Choyke PL, et al. PIRADS prostate imagingreporting and data system: 2015, version 2[J]. Eur Urol, 2016, 69(1): 1640. DOI:10.1016\/j. eururo.2015.08.052."},{"key":"5231_CR13","doi-asserted-by":"publisher","unstructured":"Park BK. Re: Baris Turkbey, Andrew B. Rosenkrantz, Masoom A. Haider, et al. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol [J]. 2019; 76: 34051. Eur Urol, 2019, 76(3): e78. https:\/\/doi.org\/10.1016\/j.eururo.2019.05.038.","DOI":"10.1016\/j.eururo.2019.05.038"},{"key":"5231_CR14","doi-asserted-by":"publisher","unstructured":"Wang Y, Wang L, Tang X, et al. Development and validation of a nomogram based on biparametric MRI PI-RADS v2.1 and clinical parameters to avoid unnecessary prostate biopsies.\u00a0BMC Med Imaging. 2023;23(1):106. Published 2023 Aug 15. https:\/\/doi.org\/10.1186\/s12880-023-01074-7","DOI":"10.1186\/s12880-023-01074-7"},{"issue":"1","key":"5231_CR15","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4261\/1305-3825.DIR.4478-11.1","volume":"18","author":"Bar\u0131\u015f T\u00fcrkbey","year":"2012","unstructured":"T\u00fcrkbey, Bar\u0131\u015f et al. \u201cMRI of localized prostate cancer: coming of age in the PSA era.\u201d Diagnostic and interventional radiology (Ankara, Turkey) vol. 18,1 (2012): 34\u201345. doi:https:\/\/doi.org\/10.4261\/1305-3825.DIR.4478-11.1","journal-title":"Diagnostic and interventional radiology (Ankara, Turkey)"},{"key":"5231_CR16","doi-asserted-by":"publisher","unstructured":"Epstein JI, Amin MB, Reuter VE, Humphrey PA. Contemporary Gleason Grading of Prostatic Carcinoma: An Update With Discussion on Practical Issues to Implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma. Am J Surg Pathol. 2017;41(4):e1-e7. doi:https:\/\/doi.org\/10.1097\/PAS.0000000000000820.","DOI":"10.1097\/PAS.0000000000000820"},{"key":"5231_CR17","doi-asserted-by":"publisher","first-page":"1096387","DOI":"10.3389\/fsurg.2022.1096387","volume":"9","author":"Y Pan","year":"2023","unstructured":"Pan Y, Shen C, Chen X, Cao D, Jiang J, Xu W, Ji C, Pan X, Zheng B. bpMRI and mpMRI for detecting prostate cancer: A retrospective cohort study. Front Surg. 2023;9:1096387. doi: 10.3389\/fsurg.2022.1096387. PMID: 36726941; PMCID: PMC9885087.","journal-title":"Front Surg"},{"key":"5231_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2019.02.033","author":"B Turkbey","year":"2019","unstructured":"Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol. 2019;76(3):340\u2013351. doi: https:\/\/doi.org\/10.1016\/j.eururo.2019.02.033. Epub 2019 Mar 18. PMID: 30898406."},{"key":"5231_CR19","doi-asserted-by":"publisher","unstructured":"Distler FA, Radtke JP, Bonekamp D, Kesch C, Schlemmer HP, Wieczorek K, Kirchner M, Pahernik S, Hohenfellner M, Hadaschik BA. The Value of PSA Density in Combination with PI-RADS\u2122 for the Accuracy of Prostate Cancer Prediction. J Urol. 2017;198(3):575-582. doi: https:\/\/doi.org\/10.1016\/j.juro.2017.03.130. Epub 2017 Mar 31. PMID: 28373135.","DOI":"10.1016\/j.juro.2017.03.130"},{"issue":"2","key":"5231_CR20","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.crad.2019.09.139","volume":"75","author":"SH Polanec","year":"2020","unstructured":"Polanec SH, Bickel H, Wengert GJ, Arnoldner M, Clauser P, Susani M, Shariat SF, Pinker K, Helbich TH, Baltzer PAT. Can the addition of clinical information improve the accuracy of PI-RADS version 2 for the diagnosis of clinically significant prostate cancer in positive MRI? Clin Radiol. 2020 Feb;75(2):157.e1-157.e7. doi:https:\/\/doi.org\/10.1038\/s41598-024-57337-y. Epub 2019 Nov 2. PMID: 31690449.","journal-title":"Clin Radiol"},{"key":"5231_CR21","doi-asserted-by":"publisher","unstructured":"Wen J, Liu W, Shen X, Hu W. PI-RADS v2.1 and PSAD for the prediction of clinically significant prostate cancer among patients with PSA levels of 4-10 ng\/ml. Sci Rep. 2024;14(1):6570. Published 2024 Mar 19. doi:https:\/\/doi.org\/10.1038\/s41598-024-57337-y.","DOI":"10.1038\/s41598-024-57337-y"},{"issue":"6","key":"5231_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.4103\/1008-682X.150846","volume":"17","author":"R Chen","year":"2015","unstructured":"Chen R, Zhou LQ, Cai XB, et al. Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(-1). Asian J Androl. 2015;17(6):1017\u20131021. doi:https:\/\/doi.org\/10.4103\/1008-682X.150846","journal-title":"Asian J Androl"},{"issue":"12","key":"5231_CR23","first-page":"7159","volume":"34","author":"S De Luca","year":"2014","unstructured":"De Luca S, Passera R, Bollito E, et al. Comparison of prostate cancer gene 3 score, prostate health index and percentage free prostate-specific antigen for differentiating histological inflammation from prostate cancer and other non-neoplastic alterations of the prostate at initial biopsy. Anticancer Res. 2014;34(12):7159\u20137165.","journal-title":"Anticancer Res"},{"issue":"1","key":"5231_CR24","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1186\/s12885-024-12495-0","volume":"24","author":"GS Li","year":"2024","unstructured":"Li GS, Huang T, Li JX, et al. Correlation between hemoglobin and the risk of common malignant tumors: a 1999-2020 retrospective analysis and causal association analysis. BMC Cancer. 2024;24(1):755. Published 2024 Jun 21. doi:https:\/\/doi.org\/10.1186\/s12885-024-12495-0.","journal-title":"BMC Cancer"},{"issue":"2","key":"5231_CR25","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/j.eururo.2014.07.028","volume":"68","author":"K Brasso","year":"2015","unstructured":"Brasso K, Thomsen FB, Schrader AJ, et al. Enzalutamide Antitumour Activity Against Metastatic Castration-resistant Prostate Cancer Previously Treated with Docetaxel and Abiraterone: A Multicentre Analysis. Eur Urol. 2015;68(2):317\u2013324. doi:https:\/\/doi.org\/10.1016\/j.eururo.2014.07.028.","journal-title":"Eur Urol"},{"issue":"18","key":"5231_CR26","doi-asserted-by":"publisher","first-page":"6365","DOI":"10.1002\/cam4.4169","volume":"10","author":"N Jia","year":"2021","unstructured":"Jia N, Zhou Y, Dong X, Ding M. The antitumor mechanisms of aerobic exercise: A review of recent preclinical studies. Cancer Med. 2021;10(18):6365\u20136373. doi:https:\/\/doi.org\/10.1002\/cam4.4169","journal-title":"Cancer Med"},{"issue":"3","key":"5231_CR27","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3390\/biom12030461","volume":"12","author":"A Garufi","year":"2022","unstructured":"Garufi A, Pistritto G, D\u2019Orazi V, Cirone M, D\u2019Orazi G. The Impact of NRF2 Inhibition on Drug-Induced Colon Cancer Cell Death and p53 Activity: A Pilot Study. Biomolecules. 2022;12(3):461. Published 2022 Mar 17. doi:https:\/\/doi.org\/10.3390\/biom12030461.","journal-title":"Biomolecules"},{"issue":"8","key":"5231_CR28","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.3390\/ijms20082025","volume":"20","author":"P Telkoparan-Akillilar","year":"2019","unstructured":"Telkoparan-Akillilar P, Suzen S, Saso L. Pharmacological Applications of Nrf2 Inhibitors as Potential Antineoplastic Drugs. Int J Mol Sci. 2019;20(8):2025. Published 2019 Apr 24. doi:https:\/\/doi.org\/10.3390\/ijms20082025.","journal-title":"Int J Mol Sci"},{"key":"5231_CR29","doi-asserted-by":"publisher","unstructured":"Bazmandegan, Gholamreza et al. \u201cPositive Association between Hemoglobin Concentration and Blood Pressure in Adults: A Cross-Sectional Study Based on Rafsanjan Cohort Study.\u201d International journal of hypertension vol. 2023 6283711. 1 Feb. 2023, doi:https:\/\/doi.org\/10.1155\/2023\/6283711","DOI":"10.1155\/2023\/6283711"},{"key":"5231_CR30","doi-asserted-by":"publisher","unstructured":"Lucarelli NM, Villanova I, Maggialetti N, et al. Quantitative ADC: An Additional Tool in the Evaluation of Prostate Cancer?. J Pers Med. 2023;13(9):1378. Published 2023 Sep 15. doi:https:\/\/doi.org\/10.3390\/jpm13091378.","DOI":"10.3390\/jpm13091378"},{"key":"5231_CR31","doi-asserted-by":"publisher","first-page":"1419310","DOI":"10.3389\/fonc.2024.1419310","volume":"14","author":"Z Chen","year":"2024","unstructured":"Chen Z, Zhang Y, Dan M, Hong X, Chen S, Zhong X. Associations of HALP score with serum prostate-specific antigen and mortality in middle-aged and elderly individuals without prostate cancer. Front Oncol. 2024;14:1419310. doi: https:\/\/doi.org\/10.3389\/fonc.2024.1419310.","journal-title":"Front Oncol"}],"container-title":["Abdominal Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05231-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00261-025-05231-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00261-025-05231-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T12:19:56Z","timestamp":1775650796000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00261-025-05231-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,13]]},"references-count":31,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["5231"],"URL":"https:\/\/doi.org\/10.1007\/s00261-025-05231-0","relation":{"references":[{"id-type":"doi","id":"10.1016\/j.","asserted-by":"subject"},{"id-type":"doi","id":"10.1016\/j.eururo.2019.02.033","asserted-by":"subject"}]},"ISSN":["2366-0058"],"issn-type":[{"value":"2366-0058","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,13]]},"assertion":[{"value":"18 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}